| Arman Borhan, MD | |
|
3212 Hickory Rd, Suite B, Mishawaka, IN 46545-8862 | |
| (574) 251-0498 | |
| (574) 251-0068 |
| Full Name | Arman Borhan |
|---|---|
| Gender | Male |
| Speciality | Physical Medicine And Rehabilitation |
| Experience | 21 Years |
| Location | 3212 Hickory Rd, Mishawaka, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1689705535 | NPI | - | NPPES |
| 1689705535 | Medicaid | IN | |
| 000000205664 | Other | IN | ANTHEM BC/BS |
| Facility Name | Location | Facility Type |
|---|---|---|
| Columbus Regional Hospital | Columbus, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Pain And Aging Management Llc | 0446291181 | 8 |
News Archive
The HHS Biomedical Advanced Research and Development Authority (BARDA) is awarding nine contracts for the advanced research and development of more effective tests and devices to determine the level of radiation a person has absorbed after a nuclear or radiological incident. The contracts total $35 million for the initial phase and up to $400 million over five years.
Four world-renowned stem cell experts have recently given their full support to private cordblood banking. The four scientists supported the "Family Cord Blood Bank" which has just been established in the US by CORD:USE.
New biological research reveals how an invading virus hijacks a cell's workings by imitating a signaling marker to defeat the body's defenses. By manipulating cell signals, the virus destroys a defensive protein designed to inhibit it. This finding, from studies in human cell cultures, may represent a broader targeting strategy used by other viruses, and may lay the scientific groundwork for developing more effective treatments for infectious diseases.
Althea Technologies, Inc., a leading provider of development and manufacturing services for biopharmaceuticals and parenteral drug products, announced today that it has completed the installation of a new INOVA H3-5 high-speed syringe filling line.
› Verified 8 days ago
| Entity Name | Pain And Aging Management Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124100961 PECOS PAC ID: 0446291181 Enrollment ID: O20050512000790 |
News Archive
The HHS Biomedical Advanced Research and Development Authority (BARDA) is awarding nine contracts for the advanced research and development of more effective tests and devices to determine the level of radiation a person has absorbed after a nuclear or radiological incident. The contracts total $35 million for the initial phase and up to $400 million over five years.
Four world-renowned stem cell experts have recently given their full support to private cordblood banking. The four scientists supported the "Family Cord Blood Bank" which has just been established in the US by CORD:USE.
New biological research reveals how an invading virus hijacks a cell's workings by imitating a signaling marker to defeat the body's defenses. By manipulating cell signals, the virus destroys a defensive protein designed to inhibit it. This finding, from studies in human cell cultures, may represent a broader targeting strategy used by other viruses, and may lay the scientific groundwork for developing more effective treatments for infectious diseases.
Althea Technologies, Inc., a leading provider of development and manufacturing services for biopharmaceuticals and parenteral drug products, announced today that it has completed the installation of a new INOVA H3-5 high-speed syringe filling line.
› Verified 8 days ago
| Entity Name | Xrs Llc |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1346322187 PECOS PAC ID: 8022023936 Enrollment ID: O20060214000578 |
News Archive
The HHS Biomedical Advanced Research and Development Authority (BARDA) is awarding nine contracts for the advanced research and development of more effective tests and devices to determine the level of radiation a person has absorbed after a nuclear or radiological incident. The contracts total $35 million for the initial phase and up to $400 million over five years.
Four world-renowned stem cell experts have recently given their full support to private cordblood banking. The four scientists supported the "Family Cord Blood Bank" which has just been established in the US by CORD:USE.
New biological research reveals how an invading virus hijacks a cell's workings by imitating a signaling marker to defeat the body's defenses. By manipulating cell signals, the virus destroys a defensive protein designed to inhibit it. This finding, from studies in human cell cultures, may represent a broader targeting strategy used by other viruses, and may lay the scientific groundwork for developing more effective treatments for infectious diseases.
Althea Technologies, Inc., a leading provider of development and manufacturing services for biopharmaceuticals and parenteral drug products, announced today that it has completed the installation of a new INOVA H3-5 high-speed syringe filling line.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Arman Borhan, MD Po Box 126, Granger, IN 46530-0126 Ph: (574) 251-0498 | Arman Borhan, MD 3212 Hickory Rd, Suite B, Mishawaka, IN 46545-8862 Ph: (574) 251-0498 |
News Archive
The HHS Biomedical Advanced Research and Development Authority (BARDA) is awarding nine contracts for the advanced research and development of more effective tests and devices to determine the level of radiation a person has absorbed after a nuclear or radiological incident. The contracts total $35 million for the initial phase and up to $400 million over five years.
Four world-renowned stem cell experts have recently given their full support to private cordblood banking. The four scientists supported the "Family Cord Blood Bank" which has just been established in the US by CORD:USE.
New biological research reveals how an invading virus hijacks a cell's workings by imitating a signaling marker to defeat the body's defenses. By manipulating cell signals, the virus destroys a defensive protein designed to inhibit it. This finding, from studies in human cell cultures, may represent a broader targeting strategy used by other viruses, and may lay the scientific groundwork for developing more effective treatments for infectious diseases.
Althea Technologies, Inc., a leading provider of development and manufacturing services for biopharmaceuticals and parenteral drug products, announced today that it has completed the installation of a new INOVA H3-5 high-speed syringe filling line.
› Verified 8 days ago
Dr. Kevin Gene Drew, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 3740 Edison Lakes Pkwy, Mishawaka, IN 46545 Phone: 574-252-4150 Fax: 574-252-4159 | |
Dr. Roger Klauer, M.D. Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 60101 Bodnar Blvd, Suite 100b, Mishawaka, IN 46544 Phone: 574-335-8500 Fax: 574-335-0794 | |
Dr. Kathryn L Park, MD Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 301 E Day Rd, Mishawaka, IN 46545 Phone: 574-237-9340 Fax: 574-239-1474 | |
Dr. Stephen Ralph Ribaudo, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 229 Red Coach Dr, Suite 102, Mishawaka, IN 46545 Phone: 574-252-5852 Fax: 574-252-5862 | |
Abhishek Das, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 5314 Lincolnway E, Mishawaka, IN 46544 Phone: 574-256-9032 Fax: 574-256-9049 |